35 results

Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic

Talaulikar, Dipti; Advani, Ranjana H.; Branagan, Andrew R.; More

HemaSphere. 4(4):e433, August 2020.

Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threatening Features Within the Early Post-engraftment Phase

Oltolini, Chiara; Guidetti, Anna; Ripa, Marco; More

HemaSphere. 4(4):e448, August 2020.

Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial

Wester, Ruth; Zweegman, Sonja; van der Holt, Bronno; More

HemaSphere. 4(4):e370, August 2020.

Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenström Macroglobulinemia on and off Clinical Trials

Castillo, Jorge J.; Gustine, Joshua N.; Meid, Kirsten; More

HemaSphere. 4(3):e363, June 2020.

Results of an Early Access Treatment Protocol of Daratumumab Monotherapy in Spanish Patients With Relapsed or Refractory Multiple Myeloma

Alegre, Adrián; de la Rubia, Javier; Sureda Balari, Anna; More

HemaSphere. 4(3):e380, June 2020.

A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Lymphoma After Nivolumab Monotherapy Failure

Lepik, Kirill V.; Mikhailova, Natalia B.; Kondakova, Elena V.; More

HemaSphere. 4(3):e401, June 2020.

Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma

Hess, Georg; Wagner, Karola; Keller, Ulrich; More

HemaSphere. 4(3):e398, June 2020.

Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study

Visentin, Andrea; Nasillo, Vincenzo; Marchetti, Monia; More

HemaSphere. 4(3):e395, June 2020.

Functional Differences Between EBV- and CMV-Specific CD8+ T cells Demonstrate Heterogeneity of T cell Dysfunction in CLL

Hofland, Tom; de Weerdt, Iris; Endstra, Sanne; More

HemaSphere. 4(2):e337, April 2020.

Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network

Drandi, Daniela; Alcantara, Marion; Benmaad, Ichrafe; More

HemaSphere. 4(2):e347, April 2020.

Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study

Morello, Lucia; Rattotti, Sara; Giordano, Laura; More

HemaSphere. 4(1):e302, February 2020.

Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group

Daw, Stephen; Hasenclever, Dirk; Mascarin, Maurizio; More

HemaSphere. 4(1):e329, February 2020.

Upfront Treatment Influences the Composition of Genetic Alterations in Relapsed Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Yu, Jiangyan; Waanders, Esmé; van Reijmersdal, Simon V.; More

HemaSphere. 4(1):e318, February 2020.

Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG)

Kutsch, Nadine; Bahlo, Jasmin; Robrecht, Sandra; More

HemaSphere. 4(1):e336, February 2020.

Low Bone Mineral Density and High Bone Turnover in Patients With Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study

Anargyrou, Konstantinos; Fotiou, Despina; Vassilakopoulos, Theodoros P.; More

HemaSphere. 3(6):e303, December 2019.

Natural Killer Cell Hypo-responsiveness in Chronic Lymphocytic Leukemia can be Circumvented In Vitro by Adequate Activating Signaling

Hofland, Tom; Endstra, Sanne; Gomes, Calum K.P.; More

HemaSphere. 3(6):e308, December 2019.

MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL)

Tisi, Maria Chiara; Ferrero, Simone; Dogliotti, Irene; More

HemaSphere. 3(6):e305, December 2019.

Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma: Updated Results of the Open-Label, International, Randomised Phase 3 HD15 Trial by the German Hodgkin Study Group

Engert, Andreas; Goergen, Helen; Markova, Jana; More

HemaSphere. 1(1):e5, December 2017.